Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients

ClinicalTrials.gov ID: NCT00418574

Public ClinicalTrials.gov record NCT00418574. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 9:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised,Double Blind, Placebo Controlled, Multicentre Trial of Abagovomab Maintenance Therapy in Patients With Epithelial Ovarian Cancer After Complete Response to First Line Chemotherapy

Study identification

NCT ID
NCT00418574
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Menarini Group
Industry
Enrollment
888 participants

Conditions and interventions

Conditions

Interventions

  • Abagovomab Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2006
Primary completion
Nov 30, 2010
Completion
May 31, 2011
Last update posted
Nov 23, 2011

2006 – 2011

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
20
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048
University of California, Los Angeles (UCLA) Los Angeles California 90095-1740
Stanford University Stanford California 94305-5317
University of Colorado Denver Colorado 80262
University of Connecticut Health Center Farmington Connecticut 06030
University of Miami Miami Florida 33136
Florida Hospital Cancer Institute Orlando Florida 32804
Curtis and Elizabeth Anderson Cancer Institute Savannah Georgia 31404
Indiana University Cancer Pavilion Indianapolis Indiana 46202
Harry and Jeanette Weinberg Cancer Institute at Franklin Square Baltimore Maryland 21237
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Wayne State University Detroit Michigan 48202
Washington University St Louis Missouri 63130
The Cancer Care Center St Louis Missouri 63141
Women's Cancer Center Las Vegas Nevada 89109
Hackensack University Medical Center, Obstetrics and Gynecology Oncology Hackensack New Jersey 07601
Roswell Park Cancer Institute Buffalo New York 14263
Memorial Sloan-Kettering Cancer Centre New York New York 10021
Duke University Medical Center Durham North Carolina 27710
University of Pittsburgh Pittsburgh Pennsylvania 15213
Women and Infants Hospital of Rhode Island Providence Rhode Island 02903
The West Clinic Memphis Tennessee 38120

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 128 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00418574, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 23, 2011 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00418574 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →